Elizabeth Juarez-Colunga
Concepts (315)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spasms, Infantile | 6 | 2024 | 122 | 1.430 |
Why?
| Vigabatrin | 2 | 2022 | 18 | 0.890 |
Why?
| Models, Statistical | 4 | 2017 | 623 | 0.790 |
Why?
| Isoantibodies | 1 | 2021 | 51 | 0.710 |
Why?
| Pseudomonas Infections | 2 | 2022 | 221 | 0.700 |
Why?
| Graft Rejection | 2 | 2021 | 598 | 0.680 |
Why?
| Machine Learning | 2 | 2021 | 443 | 0.660 |
Why?
| Arthroplasty, Replacement, Knee | 4 | 2025 | 305 | 0.620 |
Why?
| Disease Transmission, Infectious | 1 | 2019 | 55 | 0.610 |
Why?
| Vaccination Coverage | 1 | 2019 | 79 | 0.580 |
Why?
| Behavior Therapy | 2 | 2019 | 241 | 0.560 |
Why?
| Cystic Fibrosis | 4 | 2022 | 1053 | 0.550 |
Why?
| Papillomavirus Vaccines | 1 | 2019 | 232 | 0.500 |
Why?
| Health Education | 1 | 2019 | 334 | 0.500 |
Why?
| Risk Assessment | 5 | 2019 | 3240 | 0.490 |
Why?
| Internet | 2 | 2020 | 617 | 0.480 |
Why?
| Papillomavirus Infections | 1 | 2019 | 297 | 0.480 |
Why?
| Algorithms | 2 | 2021 | 1622 | 0.460 |
Why?
| Longitudinal Studies | 4 | 2017 | 2717 | 0.430 |
Why?
| Epilepsies, Myoclonic | 3 | 2018 | 45 | 0.420 |
Why?
| Data Mining | 1 | 2014 | 110 | 0.400 |
Why?
| Humans | 69 | 2025 | 129652 | 0.400 |
Why?
| Treatment Outcome | 8 | 2022 | 10230 | 0.390 |
Why?
| Osteoarthritis, Knee | 3 | 2025 | 240 | 0.380 |
Why?
| Postoperative Complications | 6 | 2018 | 2483 | 0.360 |
Why?
| Epileptic Syndromes | 3 | 2021 | 80 | 0.360 |
Why?
| Down Syndrome | 3 | 2021 | 481 | 0.340 |
Why?
| Family Planning Services | 2 | 2022 | 88 | 0.330 |
Why?
| Anti-Bacterial Agents | 2 | 2022 | 1717 | 0.330 |
Why?
| Female | 46 | 2025 | 68777 | 0.330 |
Why?
| Vision Disorders | 2 | 2021 | 135 | 0.320 |
Why?
| Contraception | 2 | 2022 | 153 | 0.320 |
Why?
| Tacrolimus | 2 | 2021 | 193 | 0.310 |
Why?
| Clinical Trials as Topic | 1 | 2013 | 1004 | 0.310 |
Why?
| Severity of Illness Index | 1 | 2017 | 2742 | 0.310 |
Why?
| Biomarkers | 4 | 2021 | 3973 | 0.300 |
Why?
| Research Design | 1 | 2013 | 1044 | 0.280 |
Why?
| Anticonvulsants | 2 | 2022 | 209 | 0.280 |
Why?
| Male | 38 | 2025 | 63682 | 0.270 |
Why?
| Advance Care Planning | 3 | 2020 | 205 | 0.270 |
Why?
| Child | 17 | 2022 | 20883 | 0.260 |
Why?
| Polycyclic Aromatic Hydrocarbons | 2 | 2016 | 27 | 0.260 |
Why?
| Veterans | 5 | 2025 | 1398 | 0.260 |
Why?
| Electroencephalography | 3 | 2024 | 403 | 0.260 |
Why?
| Walking | 4 | 2025 | 501 | 0.250 |
Why?
| Developmental Disabilities | 2 | 2019 | 261 | 0.240 |
Why?
| Hospitalization | 4 | 2020 | 2070 | 0.230 |
Why?
| Quality Improvement | 6 | 2019 | 1103 | 0.230 |
Why?
| Preoperative Care | 2 | 2016 | 340 | 0.220 |
Why?
| Retrospective Studies | 16 | 2024 | 14518 | 0.220 |
Why?
| Adipose Tissue, Brown | 1 | 2024 | 51 | 0.220 |
Why?
| Lennox Gastaut Syndrome | 2 | 2021 | 17 | 0.220 |
Why?
| Primary Health Care | 3 | 2020 | 1680 | 0.220 |
Why?
| Fluorodeoxyglucose F18 | 1 | 2024 | 129 | 0.210 |
Why?
| Exercise | 2 | 2025 | 1925 | 0.210 |
Why?
| Surgical Procedures, Operative | 2 | 2016 | 244 | 0.210 |
Why?
| Group Processes | 2 | 2020 | 57 | 0.200 |
Why?
| Logistic Models | 4 | 2021 | 1988 | 0.200 |
Why?
| Adolescent | 16 | 2024 | 20394 | 0.200 |
Why?
| Cosyntropin | 1 | 2022 | 4 | 0.190 |
Why?
| Patient Readmission | 2 | 2018 | 667 | 0.190 |
Why?
| Spasm | 1 | 2022 | 20 | 0.190 |
Why?
| Aged | 18 | 2025 | 22104 | 0.190 |
Why?
| Hospital Mortality | 2 | 2016 | 850 | 0.190 |
Why?
| Telemedicine | 3 | 2025 | 788 | 0.180 |
Why?
| Kidney Pelvis | 1 | 2021 | 24 | 0.180 |
Why?
| Exercise Therapy | 2 | 2024 | 412 | 0.180 |
Why?
| Seizures | 1 | 2024 | 402 | 0.180 |
Why?
| Disease Progression | 4 | 2022 | 2635 | 0.170 |
Why?
| Markov Chains | 2 | 2019 | 117 | 0.170 |
Why?
| Monte Carlo Method | 2 | 2019 | 143 | 0.170 |
Why?
| Ureteral Obstruction | 1 | 2021 | 62 | 0.170 |
Why?
| Amputees | 1 | 2021 | 82 | 0.170 |
Why?
| Adult | 18 | 2024 | 35577 | 0.170 |
Why?
| Sleep | 2 | 2024 | 685 | 0.170 |
Why?
| Text Messaging | 1 | 2022 | 149 | 0.170 |
Why?
| ROC Curve | 1 | 2021 | 503 | 0.170 |
Why?
| Mobile Applications | 1 | 2022 | 160 | 0.160 |
Why?
| Inpatients | 3 | 2021 | 467 | 0.160 |
Why?
| Resuscitation Orders | 1 | 2020 | 46 | 0.160 |
Why?
| Middle Aged | 17 | 2025 | 31155 | 0.160 |
Why?
| Epilepsy | 2 | 2024 | 329 | 0.160 |
Why?
| Postnatal Care | 1 | 2019 | 71 | 0.160 |
Why?
| Neurodevelopmental Disorders | 1 | 2021 | 156 | 0.160 |
Why?
| United States | 14 | 2021 | 13903 | 0.160 |
Why?
| Immunosuppressive Agents | 2 | 2021 | 853 | 0.160 |
Why?
| Tobacco Smoke Pollution | 1 | 2021 | 231 | 0.150 |
Why?
| Rural Health Services | 1 | 2019 | 111 | 0.150 |
Why?
| Gait | 1 | 2021 | 280 | 0.150 |
Why?
| Young Adult | 9 | 2024 | 12427 | 0.150 |
Why?
| Medical History Taking | 1 | 2019 | 119 | 0.150 |
Why?
| Graft Survival | 1 | 2021 | 512 | 0.150 |
Why?
| Head and Neck Neoplasms | 1 | 2023 | 544 | 0.150 |
Why?
| Proportional Hazards Models | 1 | 2021 | 1201 | 0.150 |
Why?
| Brain Waves | 1 | 2018 | 31 | 0.150 |
Why?
| Hospital Costs | 1 | 2019 | 114 | 0.150 |
Why?
| Weight Reduction Programs | 1 | 2019 | 111 | 0.150 |
Why?
| Pregnant Women | 1 | 2019 | 114 | 0.150 |
Why?
| Postoperative Care | 2 | 2017 | 241 | 0.150 |
Why?
| Automobile Driver Examination | 1 | 2017 | 9 | 0.150 |
Why?
| Delivery, Obstetric | 1 | 2019 | 137 | 0.150 |
Why?
| Lung Neoplasms | 2 | 2023 | 2344 | 0.140 |
Why?
| Radiography, Thoracic | 1 | 2019 | 168 | 0.140 |
Why?
| Antibody Formation | 1 | 2019 | 290 | 0.140 |
Why?
| Community Health Services | 1 | 2019 | 227 | 0.140 |
Why?
| Symptom Assessment | 1 | 2019 | 125 | 0.140 |
Why?
| Smoking Cessation | 1 | 2021 | 407 | 0.140 |
Why?
| Recovery of Function | 4 | 2025 | 642 | 0.140 |
Why?
| Thoracoscopy | 1 | 2017 | 52 | 0.140 |
Why?
| Mental Disorders | 2 | 2016 | 1030 | 0.140 |
Why?
| Thyrotropin | 1 | 2017 | 109 | 0.140 |
Why?
| Automobile Driving | 2 | 2016 | 140 | 0.140 |
Why?
| Computer Simulation | 1 | 2021 | 943 | 0.140 |
Why?
| Lung | 3 | 2023 | 3931 | 0.140 |
Why?
| Infant | 9 | 2024 | 9024 | 0.140 |
Why?
| Cross Infection | 1 | 2019 | 218 | 0.130 |
Why?
| Croup | 1 | 2017 | 26 | 0.130 |
Why?
| Hydrocarbons | 1 | 2016 | 27 | 0.130 |
Why?
| Transgender Persons | 1 | 2020 | 172 | 0.130 |
Why?
| Esophagectomy | 1 | 2018 | 125 | 0.130 |
Why?
| Patient Participation | 1 | 2020 | 414 | 0.130 |
Why?
| Patient Discharge | 3 | 2025 | 857 | 0.130 |
Why?
| Construction Industry | 1 | 2016 | 18 | 0.130 |
Why?
| Air Pollutants, Occupational | 1 | 2016 | 32 | 0.130 |
Why?
| Aged, 80 and over | 8 | 2021 | 7086 | 0.130 |
Why?
| Child, Preschool | 9 | 2024 | 10517 | 0.130 |
Why?
| Tissue Donors | 1 | 2019 | 391 | 0.130 |
Why?
| Cross-Sectional Studies | 7 | 2023 | 5066 | 0.130 |
Why?
| Polysomnography | 1 | 2017 | 174 | 0.130 |
Why?
| Heart Arrest | 1 | 2020 | 321 | 0.130 |
Why?
| Hormone Replacement Therapy | 1 | 2017 | 92 | 0.130 |
Why?
| Pseudomonas aeruginosa | 1 | 2019 | 347 | 0.130 |
Why?
| Pneumonectomy | 1 | 2017 | 151 | 0.130 |
Why?
| Body Composition | 1 | 2020 | 649 | 0.130 |
Why?
| Adrenocorticotropic Hormone | 1 | 2016 | 133 | 0.130 |
Why?
| Health Resources | 1 | 2017 | 114 | 0.130 |
Why?
| Medicaid | 2 | 2020 | 433 | 0.130 |
Why?
| Delivery of Health Care | 2 | 2020 | 894 | 0.130 |
Why?
| Decision Support Techniques | 1 | 2020 | 396 | 0.130 |
Why?
| Organ Transplantation | 1 | 2019 | 228 | 0.130 |
Why?
| Obesity | 2 | 2019 | 2883 | 0.120 |
Why?
| Physicians, Primary Care | 1 | 2018 | 230 | 0.120 |
Why?
| Treatment Failure | 1 | 2016 | 340 | 0.120 |
Why?
| Insulin-Like Growth Factor I | 1 | 2017 | 307 | 0.120 |
Why?
| Ultrasonography | 1 | 2019 | 716 | 0.120 |
Why?
| Risk Factors | 6 | 2019 | 9765 | 0.120 |
Why?
| Rehabilitation Centers | 1 | 2015 | 37 | 0.120 |
Why?
| Data Collection | 1 | 2017 | 650 | 0.120 |
Why?
| General Surgery | 1 | 2016 | 152 | 0.110 |
Why?
| Perception | 1 | 2017 | 340 | 0.110 |
Why?
| Physician-Patient Relations | 2 | 2016 | 539 | 0.110 |
Why?
| Diagnostic Tests, Routine | 1 | 2015 | 102 | 0.110 |
Why?
| Independent Living | 1 | 2015 | 98 | 0.110 |
Why?
| Life Change Events | 1 | 2015 | 148 | 0.110 |
Why?
| Nutrition Surveys | 1 | 2016 | 260 | 0.110 |
Why?
| Patient Admission | 1 | 2016 | 182 | 0.110 |
Why?
| Esophageal Neoplasms | 1 | 2018 | 295 | 0.110 |
Why?
| DNA Damage | 1 | 2016 | 384 | 0.110 |
Why?
| Testosterone | 1 | 2017 | 372 | 0.110 |
Why?
| Hospitals | 2 | 2016 | 637 | 0.110 |
Why?
| Respiratory Function Tests | 1 | 2016 | 586 | 0.110 |
Why?
| Vaccines | 1 | 2019 | 398 | 0.110 |
Why?
| Poisson Distribution | 1 | 2013 | 73 | 0.110 |
Why?
| Insurance, Health | 1 | 2016 | 267 | 0.110 |
Why?
| Physician's Role | 1 | 2015 | 206 | 0.110 |
Why?
| Time Factors | 4 | 2019 | 6556 | 0.100 |
Why?
| Principal Component Analysis | 1 | 2014 | 189 | 0.100 |
Why?
| Nursing Homes | 1 | 2015 | 159 | 0.100 |
Why?
| Occupational Exposure | 1 | 2016 | 299 | 0.100 |
Why?
| Sleep Apnea, Obstructive | 1 | 2017 | 275 | 0.100 |
Why?
| Kidney Transplantation | 1 | 2019 | 672 | 0.100 |
Why?
| Parents | 2 | 2021 | 1309 | 0.100 |
Why?
| Walk Test | 2 | 2023 | 70 | 0.100 |
Why?
| Cluster Analysis | 1 | 2014 | 482 | 0.100 |
Why?
| Prospective Studies | 2 | 2022 | 7133 | 0.100 |
Why?
| Databases, Factual | 4 | 2018 | 1269 | 0.100 |
Why?
| Ambulatory Care | 1 | 2016 | 504 | 0.100 |
Why?
| Cohort Studies | 5 | 2021 | 5420 | 0.090 |
Why?
| Environmental Exposure | 1 | 2016 | 463 | 0.090 |
Why?
| Insulin Resistance | 1 | 2020 | 1165 | 0.090 |
Why?
| Body Mass Index | 1 | 2020 | 2273 | 0.090 |
Why?
| Histones | 1 | 2016 | 588 | 0.090 |
Why?
| Single-Blind Method | 2 | 2021 | 271 | 0.090 |
Why?
| Length of Stay | 4 | 2018 | 1127 | 0.090 |
Why?
| Surveys and Questionnaires | 3 | 2018 | 5406 | 0.090 |
Why?
| Recurrence | 1 | 2013 | 1007 | 0.090 |
Why?
| Vaccination | 1 | 2019 | 1348 | 0.090 |
Why?
| Pregnancy Complications | 1 | 2015 | 493 | 0.090 |
Why?
| Interferon-gamma | 1 | 2014 | 770 | 0.090 |
Why?
| Child Abuse | 1 | 2015 | 517 | 0.080 |
Why?
| Age Factors | 4 | 2019 | 3144 | 0.080 |
Why?
| Preventive Health Services | 2 | 2020 | 145 | 0.080 |
Why?
| Influenza Vaccines | 1 | 2014 | 532 | 0.080 |
Why?
| Postoperative Period | 2 | 2021 | 329 | 0.080 |
Why?
| Brain Concussion | 1 | 2016 | 548 | 0.080 |
Why?
| Sex Factors | 3 | 2020 | 1968 | 0.070 |
Why?
| Guatemala | 2 | 2019 | 313 | 0.070 |
Why?
| Cognition | 1 | 2016 | 1123 | 0.070 |
Why?
| Comorbidity | 3 | 2017 | 1547 | 0.070 |
Why?
| Cardiovascular Diseases | 1 | 2020 | 2004 | 0.070 |
Why?
| NAV1.1 Voltage-Gated Sodium Channel | 2 | 2017 | 15 | 0.070 |
Why?
| Morbidity | 2 | 2019 | 302 | 0.060 |
Why?
| Mothers | 2 | 2022 | 729 | 0.060 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2024 | 1368 | 0.060 |
Why?
| Feasibility Studies | 2 | 2022 | 868 | 0.060 |
Why?
| Heart Failure | 1 | 2019 | 2150 | 0.060 |
Why?
| T-Lymphocytes | 1 | 2014 | 1928 | 0.060 |
Why?
| Survival Rate | 2 | 2020 | 1877 | 0.060 |
Why?
| Emergency Service, Hospital | 1 | 2016 | 1902 | 0.060 |
Why?
| Pilot Projects | 2 | 2020 | 1587 | 0.060 |
Why?
| Habits | 1 | 2024 | 43 | 0.060 |
Why?
| Accelerometry | 1 | 2025 | 93 | 0.050 |
Why?
| Thermogenesis | 1 | 2024 | 44 | 0.050 |
Why?
| Epilepsies, Partial | 1 | 2024 | 46 | 0.050 |
Why?
| Video Recording | 1 | 2024 | 164 | 0.050 |
Why?
| Wakefulness | 1 | 2024 | 120 | 0.050 |
Why?
| Cold Temperature | 1 | 2024 | 155 | 0.050 |
Why?
| Positron-Emission Tomography | 1 | 2024 | 288 | 0.050 |
Why?
| Gonadotropin-Releasing Hormone | 1 | 2024 | 207 | 0.050 |
Why?
| Vulnerable Populations | 1 | 2023 | 158 | 0.050 |
Why?
| Pseudomonas | 1 | 2022 | 28 | 0.050 |
Why?
| Self-Management | 1 | 2024 | 163 | 0.050 |
Why?
| Electronic Health Records | 2 | 2020 | 975 | 0.050 |
Why?
| Pregnancy | 3 | 2019 | 6402 | 0.050 |
Why?
| Cotinine | 1 | 2021 | 75 | 0.050 |
Why?
| Estrogens | 1 | 2024 | 347 | 0.050 |
Why?
| Patient Reported Outcome Measures | 1 | 2025 | 373 | 0.050 |
Why?
| Socioeconomic Factors | 2 | 2016 | 1214 | 0.050 |
Why?
| Hydronephrosis | 1 | 2021 | 34 | 0.040 |
Why?
| Milk, Human | 1 | 2022 | 151 | 0.040 |
Why?
| Smoking Prevention | 1 | 2021 | 163 | 0.040 |
Why?
| Pennsylvania | 1 | 2020 | 108 | 0.040 |
Why?
| Michigan | 1 | 2020 | 104 | 0.040 |
Why?
| Quadriceps Muscle | 1 | 2021 | 128 | 0.040 |
Why?
| Urologic Surgical Procedures | 1 | 2021 | 107 | 0.040 |
Why?
| Home Health Nursing | 1 | 2019 | 10 | 0.040 |
Why?
| Oral Health | 1 | 2021 | 130 | 0.040 |
Why?
| Postpartum Period | 1 | 2022 | 332 | 0.040 |
Why?
| Health Plan Implementation | 1 | 2020 | 137 | 0.040 |
Why?
| Health Behavior | 1 | 2024 | 741 | 0.040 |
Why?
| Reproductive Health | 1 | 2019 | 86 | 0.040 |
Why?
| Muscle Strength | 1 | 2021 | 303 | 0.040 |
Why?
| Colorado | 2 | 2020 | 4421 | 0.040 |
Why?
| Glucose | 1 | 2024 | 1003 | 0.040 |
Why?
| Follow-Up Studies | 2 | 2020 | 4897 | 0.040 |
Why?
| Breast Feeding | 1 | 2022 | 424 | 0.040 |
Why?
| Documentation | 1 | 2020 | 184 | 0.040 |
Why?
| Peer Group | 1 | 2020 | 225 | 0.040 |
Why?
| Biomechanical Phenomena | 1 | 2021 | 764 | 0.040 |
Why?
| House Calls | 1 | 2019 | 123 | 0.040 |
Why?
| Energy Metabolism | 1 | 2024 | 874 | 0.040 |
Why?
| Safety-net Providers | 1 | 2019 | 109 | 0.040 |
Why?
| Chi-Square Distribution | 1 | 2019 | 516 | 0.040 |
Why?
| Mentoring | 1 | 2020 | 131 | 0.040 |
Why?
| Lower Extremity | 1 | 2021 | 404 | 0.040 |
Why?
| Snoring | 1 | 2017 | 12 | 0.040 |
Why?
| Choice Behavior | 1 | 2019 | 165 | 0.040 |
Why?
| Perioperative Period | 1 | 2017 | 49 | 0.040 |
Why?
| Genetic Association Studies | 1 | 2019 | 360 | 0.030 |
Why?
| Cesarean Section | 1 | 2019 | 182 | 0.030 |
Why?
| Cardiopulmonary Resuscitation | 1 | 2020 | 232 | 0.030 |
Why?
| Point-of-Care Systems | 1 | 2019 | 147 | 0.030 |
Why?
| Preoperative Period | 1 | 2017 | 115 | 0.030 |
Why?
| Neonatal Screening | 1 | 2018 | 163 | 0.030 |
Why?
| Oximetry | 1 | 2017 | 87 | 0.030 |
Why?
| Deoxyguanosine | 1 | 2016 | 25 | 0.030 |
Why?
| Women's Health | 1 | 2019 | 365 | 0.030 |
Why?
| Body Height | 1 | 2017 | 193 | 0.030 |
Why?
| Urban Population | 1 | 2019 | 441 | 0.030 |
Why?
| Emotional Adjustment | 1 | 2016 | 16 | 0.030 |
Why?
| Mutation | 2 | 2017 | 3717 | 0.030 |
Why?
| Cost-Benefit Analysis | 1 | 2019 | 569 | 0.030 |
Why?
| Adipose Tissue | 1 | 2020 | 592 | 0.030 |
Why?
| Housing for the Elderly | 1 | 2015 | 7 | 0.030 |
Why?
| Models, Theoretical | 1 | 2019 | 547 | 0.030 |
Why?
| Financing, Personal | 1 | 2015 | 26 | 0.030 |
Why?
| Factor Analysis, Statistical | 1 | 2016 | 284 | 0.030 |
Why?
| Medicare | 1 | 2020 | 720 | 0.030 |
Why?
| Health Surveys | 1 | 2017 | 494 | 0.030 |
Why?
| History, 21st Century | 1 | 2016 | 183 | 0.030 |
Why?
| Rural Population | 1 | 2019 | 518 | 0.030 |
Why?
| Probability | 1 | 2016 | 306 | 0.030 |
Why?
| International Classification of Diseases | 1 | 2015 | 122 | 0.030 |
Why?
| Risk | 1 | 2017 | 854 | 0.030 |
Why?
| Lymphocytes | 1 | 2016 | 377 | 0.030 |
Why?
| Depression | 1 | 2023 | 1307 | 0.030 |
Why?
| Geriatric Assessment | 1 | 2016 | 205 | 0.030 |
Why?
| Patient Acceptance of Health Care | 1 | 2020 | 759 | 0.030 |
Why?
| Nervous System Diseases | 1 | 2017 | 252 | 0.030 |
Why?
| Forced Expiratory Volume | 1 | 2016 | 511 | 0.030 |
Why?
| Smoking | 1 | 2021 | 1501 | 0.030 |
Why?
| Environmental Monitoring | 1 | 2016 | 318 | 0.030 |
Why?
| Weight Loss | 1 | 2019 | 734 | 0.030 |
Why?
| Data Interpretation, Statistical | 1 | 2016 | 335 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2019 | 1952 | 0.030 |
Why?
| Quality Indicators, Health Care | 1 | 2016 | 298 | 0.030 |
Why?
| Life Style | 1 | 2016 | 460 | 0.030 |
Why?
| Health Services Research | 1 | 2016 | 391 | 0.030 |
Why?
| Health Care Surveys | 1 | 2015 | 559 | 0.030 |
Why?
| Body Weight | 1 | 2017 | 940 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2017 | 1838 | 0.030 |
Why?
| Disease Management | 1 | 2017 | 589 | 0.030 |
Why?
| Oxygen | 1 | 2017 | 915 | 0.020 |
Why?
| Case-Control Studies | 1 | 2020 | 3381 | 0.020 |
Why?
| Surgeons | 1 | 2016 | 261 | 0.020 |
Why?
| Intensive Care Units | 1 | 2017 | 738 | 0.020 |
Why?
| Registries | 1 | 2020 | 1896 | 0.020 |
Why?
| Hospitals, Pediatric | 1 | 2015 | 509 | 0.020 |
Why?
| Quality of Life | 1 | 2023 | 2704 | 0.020 |
Why?
| Cognition Disorders | 1 | 2016 | 505 | 0.020 |
Why?
| Prognosis | 1 | 2020 | 3794 | 0.020 |
Why?
| Neuropsychological Tests | 1 | 2016 | 1015 | 0.020 |
Why?
| Cognitive Dysfunction | 1 | 2016 | 346 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2016 | 3083 | 0.020 |
Why?
| Infant, Newborn | 1 | 2018 | 5762 | 0.020 |
Why?
|
|
Juarez-Colunga's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|